Categories: News

Elliott Management Releases Presentation on Toyota Industries Corporation

Elliott does not intend to tender its shares into the Revised TOB at the current terms and strongly encourages other shareholders not to tender

- Advertisement -

LONDON, Jan. 27, 2026 /PRNewswire/ — Elliott Investment Management L.P. and Elliott Advisors (UK) Limited (“Elliott”), which advise funds that together have a significant ownership stake in Toyota Industries Corporation (“Toyota Industries” or the “Company”), today released an investor presentation titled “Elliott’s Perspectives on Toyota Industries.”

- Advertisement -

In the presentation, Elliott, the largest independent shareholder of Toyota Industries, outlined its opposition to the revised tender offer by Toyota Fudosan Co., Ltd. at ¥18,800 per share (the “Revised TOB”), which Elliott believes very significantly undervalues Toyota Industries. Elliott’s analysis showed the Company’s intrinsic net asset value to be more than ¥26,000 per share as of January 16, 2026 – almost 40% above the Revised TOB price.

- Advertisement -

Elliott’s presentation also outlined the Standalone Plan for Toyota Industries, which offers a far more compelling option for shareholders than the Revised TOB. The Standalone Plan – including full cross-shareholding unwind and operational improvements – offers a clear path to an intrinsic net asset value of more than ¥40,000 per share by 2028, representing more than 120% upside to the Revised TOB price.

- Advertisement -

The presentation described the significant deficiencies in the transaction governance process and noted that if the Revised TOB succeeds, it would represent a setback for Japan’s corporate governance reforms and dampen investor interest in the Japanese market.

- Advertisement -

Elliott does not intend to tender its shares into the Revised TOB at the current terms and strongly encourages other shareholders not to tender.

- Advertisement -

The presentation can be viewed at https://elliottletters.com

- Advertisement -

About Elliott

- Advertisement -

Elliott Investment Management L.P. (together with its affiliates, “Elliott”) manages approximately $76.1 billion of assets as of June 30, 2025. Founded in 1977, it is one of the oldest funds under continuous management. The Elliott funds’ investors include pension plans, sovereign wealth funds, endowments, foundations, funds-of-funds, high net worth individuals and families, and employees of the firm. Elliott Advisors (UK) Limited is an affiliate of Elliott Investment Management L.P.

- Advertisement -

Investor Contacts:

- Advertisement -

Okapi Partners LLC
New York: Pat McHugh
T:+1 212 297 0720
Toll Free: (877) 629-6357
London: Christian Jacques
T: +44 20 3031 6613
TICO@okapipartners.com

- Advertisement -

Media Contacts:

- Advertisement -

London
Stijn van de Grampel
Elliott Advisors (UK) Limited
T: +44 20 3009 1061
svdgrampel@elliottadvisors.co.uk

- Advertisement -

New York
Stephen Spruiell
Elliott Investment Management L.P.
T: +1 (212) 478-2017
sspruiell@elliottmgmt.com

- Advertisement -

Tokyo
Brett Wallbutton
Ashton Consulting
T: +81 (0) 3 5425-7220
b.wallbutton@ashton.jp 

- Advertisement -

Logo – https://mma.prnewswire.com/media/2705826/5734630/Elliott_WhiteText_Green_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/elliott-management-releases-presentation-on-toyota-industries-corporation-302670662.html

- Advertisement -

Recent Posts

New Guidelines from NCCN Detail Fundamental Differences in Cancer in Children Compared to Adults

National Comprehensive Cancer Network publishes new guidelines for Pediatric Soft Tissue Sarcomas, focused on rhabdomyosarcoma.PLYMOUTH…

4 hours ago

FDA 510(k) Clearance Establishes Broad Intended Use for Copan’s PhenoMATRIX, Expanding Clinical Microbiology Capabilities

MURRIETA, Calif., Feb. 17, 2026 /PRNewswire/ -- Copan Group announced today that PhenoMATRIX®, its automated…

4 hours ago

Metabolon’s Metabolomics Platform Enables Largest Metabolomic Analysis to Date in CAR T-Cell Therapy, Revealing New Insights into Severe Neurotoxicity

Metabolomics-Derived Pathway Scores Outperform Inflammatory Protein Markers—Delivering Risk Prediction Where Proteomics Falls ShortMORRISVILLE, N.C., Feb.…

4 hours ago

Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage

Headlines:Delivers up to 2× higher sensitivity than stainless steel microflow columns, lowering detection and quantitation limits…

4 hours ago

VyOS Networks Showcases High-Performance, Sovereign Networking with VyOS 1.5 LTS at Mobile World Congress Barcelona (MWC) 2026

Meet VyOS at Congress Square, Stand CS73, to standardize high-performance routing, firewalling, and VPN across…

9 hours ago

IP Strategy Issues Statement on Arias Frontline K-Pop Release with RESCENE, Highlighting AI-Native Music Ownership on Story

GIG HARBOR, Wash., Feb. 17, 2026 (GLOBE NEWSWIRE) -- IP Strategy (Nasdaq: IPST) (the “Company”)…

9 hours ago